Affordable Access

A lazaroid mitigates postresuscitation myocardial dysfunction.

Authors
  • Wang, Jinglan
  • Weil, Max Harry
  • Kamohara, Takashi
  • Tang, Wanchun
  • Sun, Shijie
  • Klouche, Kada
  • Bisera, Joe
Type
Published Article
Journal
Critical Care Medicine
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Feb 01, 2004
Volume
32
Issue
2
Pages
553–558
Identifiers
PMID: 14758178
Source
Medline
License
Unknown

Abstract

The lazaroid compound U-74389G, administered during cardiac arrest, mitigated postresuscitation myocardial dysfunction and improved survival.

Report this publication

Statistics

Seen <100 times